Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quad screen as a predictor of adverse pregnancy outcome.
Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH, Saade G, Eddleman K, Merkatz IR, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME; FASTER Trial Research Consortium. Dugoff L, et al. Among authors: eddleman k. Obstet Gynecol. 2005 Aug;106(2):260-7. doi: 10.1097/01.AOG.0000172419.37410.eb. Obstet Gynecol. 2005. PMID: 16055573
Pregnancy loss rates after midtrimester amniocentesis.
Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, Porter TF, Luthy DA, Comstock CH, Saade GR, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. Eddleman KA, et al. Obstet Gynecol. 2006 Nov;108(5):1067-72. doi: 10.1097/01.AOG.0000240135.13594.07. Obstet Gynecol. 2006. PMID: 17077226 Clinical Trial.
Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers.
Dugoff L, Cuckle HS, Hobbins JC, Malone FD, Belfort MA, Nyberg DA, Comstock CH, Saade GR, Eddleman KA, Dar P, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME; FaSTER Trial Research Consortium. Dugoff L, et al. Am J Obstet Gynecol. 2008 Sep;199(3):290.e1-6. doi: 10.1016/j.ajog.2008.06.099. Am J Obstet Gynecol. 2008. PMID: 18771987
Impact of maternal age on obstetric outcome.
Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, Saade GR, Eddleman KA, Klugman S, Dugoff L, Timor-Tritsch IE, Craigo SD, Carr SR, Wolfe HM, Bianchi DW, D'Alton M; FASTER Consortium. Cleary-Goldman J, et al. Obstet Gynecol. 2005 May;105(5 Pt 1):983-90. doi: 10.1097/01.AOG.0000158118.75532.51. Obstet Gynecol. 2005. PMID: 15863534
Assisted reproductive technology and pregnancy outcome.
Shevell T, Malone FD, Vidaver J, Porter TF, Luthy DA, Comstock CH, Hankins GD, Eddleman K, Dolan S, Dugoff L, Craigo S, Timor IE, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME. Shevell T, et al. Among authors: eddleman k. Obstet Gynecol. 2005 Nov;106(5 Pt 1):1039-45. doi: 10.1097/01.AOG.0000183593.24583.7c. Obstet Gynecol. 2005. PMID: 16260523
Nuchal translucency and the risk of congenital heart disease.
Simpson LL, Malone FD, Bianchi DW, Ball RH, Nyberg DA, Comstock CH, Saade G, Eddleman K, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, D'Alton ME. Simpson LL, et al. Among authors: eddleman k. Obstet Gynecol. 2007 Feb;109(2 Pt 1):376-83. doi: 10.1097/01.AOG.0000250473.99575.72. Obstet Gynecol. 2007. PMID: 17267839
Role of second-trimester genetic sonography after Down syndrome screening.
Aagaard-Tillery KM, Malone FD, Nyberg DA, Porter TF, Cuckle HS, Fuchs K, Sullivan L, Comstock CH, Saade GR, Eddleman K, Gross S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Research Consortium. Aagaard-Tillery KM, et al. Among authors: eddleman k. Obstet Gynecol. 2009 Dec;114(6):1189-1196. doi: 10.1097/AOG.0b013e3181c15064. Obstet Gynecol. 2009. PMID: 19935018 Free PMC article. Clinical Trial.
Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy.
Haddow JE, McClain MR, Lambert-Messerlian G, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME; First and Second Trimester Evaluation of Risk for Fetal Aneuploidy Research Consortium. Haddow JE, et al. J Clin Endocrinol Metab. 2008 Sep;93(9):3341-7. doi: 10.1210/jc.2008-0568. Epub 2008 Jun 10. J Clin Endocrinol Metab. 2008. PMID: 18544616 Free PMC article.
First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study.
Lambert-Messerlian G, McClain M, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME; FaSTER Research Consortium. Lambert-Messerlian G, et al. Am J Obstet Gynecol. 2008 Jul;199(1):62.e1-6. doi: 10.1016/j.ajog.2007.12.003. Am J Obstet Gynecol. 2008. PMID: 18585522 Free PMC article.
The effect of low body mass index on the development of gestational hypertension and preeclampsia.
Belogolovkin V, Eddleman KA, Malone FD, Sullivan L, Ball RH, Nyberg DA, Comstock CH, Hankins GD, Carter S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. Belogolovkin V, et al. J Matern Fetal Neonatal Med. 2007 Jul;20(7):509-13. doi: 10.1080/14767050701420027. J Matern Fetal Neonatal Med. 2007. PMID: 17674263 Free article. Clinical Trial.
65 results